improving patient outcomes in ctcl: clinical collaboration and novel agents
Published 1 year ago • 43 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
0:53
improving quality of life outcomes for patients with scd
-
2:31
improving patient outcomes and extending survival in cll
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:46
optimizing conditioning regimens in patients with aml undergoing allosct
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
5:31
how will ai tools and llms help to transform medicine and cancer care in the future?
-
12:07
how to raise hemoglobin naturally | sickle cell chats | healing blends global
-
14:43
current research into post-allosct maintenance therapy in aml
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
1:09
sequencing of therapies to improve outcomes of cll patients
-
1:18
involving the patient in treatment decisions for cll
-
1:52
critical insight into therapeutic progress for ctcl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
8:57
outcomes of sct in t-all and t-lbl
-
2:09
heart transplantation in attr amyloidosis
-
1:12
strategies to improve the quality of life of patients with mpns
-
3:16
improving upon the standard of care for patients with richter’s transformation
-
3:07
barriers to progressing cll treatment in taiwan: treatment access and biomarkers
-
2:22
how hematologists can improve care for patients with sickle cell disease